A. Hadengue

703 total citations
36 papers, 577 citations indexed

About

A. Hadengue is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, A. Hadengue has authored 36 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 12 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in A. Hadengue's work include Liver Disease and Transplantation (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (5 papers). A. Hadengue is often cited by papers focused on Liver Disease and Transplantation (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (5 papers). A. Hadengue collaborates with scholars based in France, Switzerland and Italy. A. Hadengue's co-authors include Didier Lebrec, Catherine Girod, Alain Braillon, Jaime Levenson, Laura Rubbia‐Brandt, Jean‐François Dufour, J. J. Gonvers, Beat Helbling, Gioacchino Leandro and R Malinverni and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Hypertension.

In The Last Decade

A. Hadengue

35 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hadengue France 12 345 286 146 97 94 36 577
F.J. Carrilho Brazil 7 288 0.8× 276 1.0× 163 1.1× 63 0.6× 60 0.6× 21 521
Takumi Akiyama Japan 12 249 0.7× 272 1.0× 163 1.1× 82 0.8× 119 1.3× 25 534
Yoshiro Taki Japan 15 296 0.9× 276 1.0× 362 2.5× 105 1.1× 145 1.5× 52 751
Raffi Karagozian United States 14 205 0.6× 332 1.2× 198 1.4× 118 1.2× 80 0.9× 52 658
Gül Yüce Türkiye 15 251 0.7× 286 1.0× 286 2.0× 26 0.3× 110 1.2× 45 630
Jason M. Vanatta United States 15 392 1.1× 235 0.8× 315 2.2× 56 0.6× 42 0.4× 40 624
Ian Schreibman United States 14 316 0.9× 360 1.3× 240 1.6× 60 0.6× 92 1.0× 36 745
Minoru Ukikusa Japan 13 250 0.7× 244 0.9× 270 1.8× 127 1.3× 32 0.3× 46 560
Assaf Issachar Israel 13 273 0.8× 298 1.0× 133 0.9× 47 0.5× 45 0.5× 27 620
Xiaoping Wu China 11 345 1.0× 217 0.8× 226 1.5× 57 0.6× 97 1.0× 29 735

Countries citing papers authored by A. Hadengue

Since Specialization
Citations

This map shows the geographic impact of A. Hadengue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hadengue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hadengue more than expected).

Fields of papers citing papers by A. Hadengue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hadengue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hadengue. The network helps show where A. Hadengue may publish in the future.

Co-authorship network of co-authors of A. Hadengue

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hadengue. A scholar is included among the top collaborators of A. Hadengue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hadengue. A. Hadengue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouattour, Mohamed, Clément Dumont, Laëtitia Dahan, et al.. (2025). Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN ‐ CK GERCOR Phase II Trial. Liver International. 45(8). e70196–e70196. 1 indexed citations
2.
Bouattour, Mohamed, Lætitia Fartoux, Olivier Rosmorduc, et al.. (2016). BIOSHARE multicenter neoadjuvant phase 2 study: Results of pre-operative sorafenib in patients with resectable hepatocellular carcinoma (HCC)—From GERCOR IRC.. Journal of Clinical Oncology. 34(4_suppl). 252–252. 13 indexed citations
3.
Chibaudel, Benoist, Franck Bonnetain, Christophe Tournigand, et al.. (2015). STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer. BMC Cancer. 15(1). 496–496. 17 indexed citations
4.
Diouf, Momar, Benoist Chibaudel, Thomas Filleron, et al.. (2014). Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Health and Quality of Life Outcomes. 12(1). 69–69. 28 indexed citations
5.
Raymond, Éric, Christophe Le Tourneau, Michel Gatineau, et al.. (2013). CAPRA: Safety, efficacy, and translational biomarkers of weekly everolimus, carboplatin, and paclitaxel as induction therapy for locally advanced head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 31(15_suppl). 6036–6036. 12 indexed citations
6.
Goossens, Nicolas, et al.. (2012). [Coagulation and cirrhosis: new insight].. PubMed. 8(352). 1652, 1654–6. 2 indexed citations
7.
Gottardi, Andrea De, Thierry Thévenot, Laurent Spahr, et al.. (2009). 184 RISK OF COMPLICATIONS AFTER ABDOMINAL PARACENTESIS IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY. Journal of Hepatology. 50. S77–S77. 9 indexed citations
8.
Murad, Sarwa Darwish, Aurélie Plessier, Massimo Primignani, et al.. (2007). [3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE). Journal of Hepatology. 46. S4–S4. 17 indexed citations
9.
Negro, Francesco & A. Hadengue. (2006). [Therapy of chronic hepatitis B].. PubMed. 2(77). 1981–2, 1984. 2 indexed citations
10.
Negro, F. & A. Hadengue. (2006). Prise en charge de l'hépatite B chronique. Forum Médical Suisse ‒ Swiss Medical Forum. 6(42). 1 indexed citations
11.
Rouffiac, Valérie, et al.. (2002). A New Ultrasound Principle for Characterizing Erythrocyte Aggregation. Investigative Radiology. 37(8). 413–420. 7 indexed citations
12.
Quadri, Rafael, Emile Giostra, Laura Rubbia‐Brandt, et al.. (2000). Mechanism of action of ribavirin in treatment of recurrent hepatitis c after liver transplant. Journal of Hepatology. 32. 91–91. 7 indexed citations
13.
Hadengue, A., et al.. (1998). Erythrocyte Disaggregation Shear Stress, Sialic Acid, and Cell Aging in Humans. Hypertension. 32(2). 324–330. 49 indexed citations
14.
Negro, F., Mauro Papotti, Stefano Taraglio, et al.. (1997). Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non‐neoplastic liver tissues. Journal of Viral Hepatitis. 4(2). 93–98. 6 indexed citations
15.
Moreau, Richard, A. Hadengue, Christophe Gaudin, et al.. (1992). [Effect of the severity of liver disease on renal hemodynamics and renal oxygen consumption in patients with cirrhosis].. PubMed. 16(4). 309–13. 1 indexed citations
16.
Gaudin, Christophe, Alain Braillon, Richard Moreau, et al.. (1992). [Renal sympathetic nervous activity in patients with cirrhosis].. PubMed. 16(6-7). 498–503. 1 indexed citations
17.
Bacq, Yannick, Christophe Gaudin, A. Hadengue, et al.. (1989). Splanchnic and renal hemodynamic effects of dopaminergic dose of dopamine in cirrhotic patients with ascites. Hepatology. 10(4). 717. 2 indexed citations
18.
Moreau, Richard, Alain Braillon, Dominique Roulot, et al.. (1989). [Tissue hypoxia and hepatocellular insufficiency in patients with cirrhosis].. PubMed. 13(12). 978–83. 8 indexed citations
19.
Hadengue, A., et al.. (1988). Regional Blood Flows by the Microsphere Method: Reproducibility in Portal Hypertensive Rats and Influence of a Portal Vein Catheter. Experimental Biology and Medicine. 187(4). 461–468. 26 indexed citations
20.
Garcin, R, et al.. (1958). [Medullary compression due to extradural congenital spinal cyst in a 6 year old child; surgery, cure, with subsequent development of kyphosis].. PubMed. 98(1). 54–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F.J. Carrilho Breakdown of academic impact, for papers by Takumi Akiyama Breakdown of academic impact, for papers by Yoshiro Taki Breakdown of academic impact, for papers by Raffi Karagozian Breakdown of academic impact, for papers by Gül Yüce Breakdown of academic impact, for papers by Jason M. Vanatta Breakdown of academic impact, for papers by Ian Schreibman Breakdown of academic impact, for papers by Minoru Ukikusa Breakdown of academic impact, for papers by Assaf Issachar Breakdown of academic impact, for papers by Xiaoping Wu
Rankless by CCL
2026